AB vs DEO: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: AB is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AB and DEO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AB and DEO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

AllianceBernstein is a global investment management firm that runs research-intensive active strategies across equities, fixed income, alternatives, and multi-asset portfolios. It serves three client channels: Institutional Services (pensions, endowments, insurers, and central banks), Retail Services (mutual funds and separately managed accounts), and Private Wealth Management for high-net-worth families. Assets under management reached about $905 billion by mid-2026, split fairly evenly across institutional, retail, and private-wealth clients, and the firm earns the bulk of its revenue from asset-based management fees plus performance fees and Bernstein Research services. Equitable Holdings (EQH) is the controlling owner, holding a large majority economic interest through the operating partnership.

Full AB guide

Diageo plc is the largest spirits producer in the world by value, selling in roughly 180 markets from a portfolio that spans Johnnie Walker, Buchanan's and other Scotch, Smirnoff and Ketel One vodka, Tanqueray and Gordon's gin, Captain Morgan rum, Crown Royal Canadian whisky, Bulleit bourbon, Baileys, the Don Julio and Casamigos tequilas, and Guinness stout. It also holds controlling stakes in listed subsidiaries including United Spirits in India, and has been reshaping the edges of the group: East Africa Breweries is being sold with completion expected in calendar H2 2026, and United Spirits is divesting the Royal Challengers Bengaluru cricket franchise. The economics are those of a branded-goods owner rather than a manufacturer, with pricing power, long aging cycles for whisky and tequila that tie up working capital, and distribution scale that is hard to replicate.

Full DEO guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AB drivers: Assets under management scale; Distribution-driven income.
• DEO drivers: The cost program and margin defence; Deleveraging and the reset dividend.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: AB's revenue is tightly linked to markets, so a downturn in equities or bonds would shrink the fee base and the distribution alongside it. For DEO, the core risk is that the spirits downturn is structural rather than cyclical: US consumption has been falling since the post-pandemic peak, and moderation trends among younger drinkers, GLP-1 weight-loss drugs and cannabis substitution are all cited as reasons the volume base may not recover to prior trend.

Pick AB if you believe its drivers more; DEO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AB and DEO guides.

AB. AB trades at a modest earnings multiple (roughly 11x trailing) that reflects its status as a mature, market-sensitive asset manager rather than a growth stock. The standout feature is the high distribution yield near 9%, which is a function of the MLP pass-through structure that returns almost all cash to unitholders each quarter. Because the payout floats with adjusted profit, both the yield and the multiple should be read against the risk that markets or flows turn negative.

DEO. At roughly $94 per ADR against ~$6.61 of ADR-equivalent earnings before exceptional items, DEO trades near ~14x, well below the 20x-plus multiple it carried through the 2010s and much of the pandemic era. The reported figure looks very different: basic EPS of ~78.1 cents (~$3.12 per ADR) reflects ~$1.5 billion of impairments and ~$0.9 billion of restructuring, so the headline P/E on statutory earnings is roughly double. Enterprise value including ~$20.5 billion of net debt is around $73 billion, or roughly 11x adjusted EBITDA.

Headline figures (approximate, JULY 2026): AB shows assets under management ~$905B, revenue (ttm, gaap) ~$4.5B, q1 2026 adjusted epu ~$0.83, quarterly distribution ~$0.83/unit; DEO shows net sales (fy2026) ~$19.6B, -3.0% reported, -2.0% organic, operating profit (before exceptionals) ~$5.7B, ~28.9% margin, eps before exceptional items ~165.3c per share (~$6.61 per ADR), free cash flow (fy2026) ~$3.2B.

AB and DEO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AB and DEO exposure against your real portfolio. It is not an investment adviser.